Evidence map›Paper›PMID 19189990›Full record

ArticleHealth affairs (Project Hope)

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits.

Sebastian Schneeweiss, Amanda R Patrick, Alex Pedan, Laleh Varasteh, Raisa Levin, Nan Liu, William H Shrank

Abstract read
In one paragraph

Article in Health affairs (Project Hope). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pharmaceutical policies: effects of regulating drug insurance schemes.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2017
    Article
  12. How Did Medicare Part D Affect Racial and Ethnic Disparities in Drug Coverage?The journals of gerontology. Series B, Psychological sciences and social sciences · 2016
    Article
  13. Article
  14. Article
  15. Observational
  16. Observational
  17. Article
  18. Effects of Medicare Part D coverage gap on medication adherence.The American journal of managed care · 2013
    Article
  19. Dementia and out-of-pocket spending on health care services.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston, Massachusetts, USA. sschneeweiss@partners.org
Amanda R Patrick
Alex Pedan
Laleh Varasteh
Raisa Levin
Nan Liu
William H Shrank

Funding

Impact of Medicare Drug Coverage on Antidepressant Quality and OutcomesU01MH079175 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHNEEWEISS, SEBASTIAN G. · 2007 to 2010
$1.6M
An intervention to improve rational prescribing in cardiovascular diseaseK23HL090505 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SHRANK, WILLIAM · 2007 to 2010
$650k
NHLBI NIH HHS K23 HL090505NHLBI NIH HHS K23HL090505-01NIMH NIH HHS R01-MH 079175NIMH NIH HHS U01 MH079175
6 · The paper itself

Abstract

This study evaluates the effect of Medicare Part D among seniors who previously lacked drug coverage, using time-trend analyses of patient-level dispensing data from three pharmacy chains. Of 114,766 seniors without drug benefits, 55 percent initiated drug insurance under Part D. After the penalty-free Part D enrollment period, use of statins, clopidogrel, and proton pump inhibitors stabilized at levels ranging from 11 percent to 37 percent above the trend that would have been expected if Part D had not been implemented. Patients reaching the Part D coverage gap (12 percent) experienced a decrease in essential medication use ranging from 5.7 percentage points per month for warfarin to 6.3 percentage points for statins.

Indexed as

Cost SharingAgedAged, 80 and overFemaleHealth Services for the AgedHumansMaleMedicaidMedicare Part DUnited States

Identifiers

PMID19189990
PMCPMC2683877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.